A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 7,412 shares of TSHA stock, worth $18,307. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,412
Previous 5,583 32.76%
Holding current value
$18,307
Previous $12,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$2.01 - $2.46 $3,676 - $4,499
1,829 Added 32.76%
7,412 $14,000
Q2 2024

Jul 30, 2024

BUY
$2.04 - $4.17 $11,389 - $23,281
5,583 New
5,583 $12,000

Others Institutions Holding TSHA

About Taysha Gene Therapies, Inc.


  • Ticker TSHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,359,500
  • Market Cap $119M
  • Description
  • Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...
More about TSHA
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.